Trials / Conditions / Solid Tumors and Lymphomas
Solid Tumors and Lymphomas
3 registered clinical trials studyying Solid Tumors and Lymphomas.
| Status | Trial | Sponsor | Phase |
|---|---|---|---|
| Terminated | Study of the Safety and Efficacy of MIW815 With PDR001 in Patients With Advanced/Metastatic Solid Tumors or Ly NCT03172936 | Novartis Pharmaceuticals | Phase 1 |
| Completed | Study to Evaluate Safety, Tolerability, Pharmacokinetics, and Pharmacodynamics of Alobresib (Formerly GS-5829) NCT02392611 | Gilead Sciences | Phase 1 |
| Withdrawn | Safety and Efficacy of GMX1777 in the Treatment of Refractory Solid Tumors or Lymphomas NCT00457574 | Gemin X | Phase 1 |